VSee Health, Inc. (VSEE)

As of May 8, 2026, VSee Health, Inc. (VSEE) stock was trading at $0.18, reflecting a +2.94% move since the market opened on that day. On January 1st, 2026, VSEE's stock was trading at $0.3744, and since then, shares have decreased by 51.9%. The 52-week high for VSEE stock was $2.52, and the 52-week low was $0.17 or $0.18. VSee Health unveiled the world's first autonomous telehealth AI robot at HIMSS 2026 on April 19, 2026. On April 2, 2026, the company reported its financial and operational results for the full year ended December 31, 2025, showing revenue growth of 40% year-over-year and announced strategic partnerships, including one with GoMyRx and another with DocBox. VSEE launched an AI-driven rural health transformation platform on April 2, 2026. News regarding VSee Health's autonomous telehealth AI robot at HIMSS 2026 was reported on March 10, 2026. On April 2, 2025, VSee Health highlighted its AI-powered telehealth platform, modular approach, expanding partnerships, and strategic growth, noting its market presence expansion since listing on Nasdaq in mid-2024 despite short-seller activity.

While specific detailed information on demand seasonality for VSee Health, Inc. products and services is not extensively provided, one snippet mentions the availability of "powerful data on market seasonality" for VSEE, suggesting that seasonal patterns might exist and are tracked. Generally, telehealth services can experience fluctuations based on factors such as flu seasons, public health crises, and changes in healthcare policies or insurance coverage. The company's focus on critical care and acute conditions might suggest a more consistent demand, but broader adoption of telehealth could still be influenced by seasonal health trends.

VSee Health, Inc. is a telehealth technology company providing comprehensive telehealth care solutions, primarily in the United States. It offers a modular, no-code/low-code SaaS platform for hospitals and enterprises, operating in the Healthcare sector, specifically in Health Information Services and Healthcare Providers & Services industries, and is also categorized under Software & IT Services and Technology. The company's core business model is B2B, selling software subscriptions to clinics and independent practitioners through recurring monthly or annual fees. Its offerings allow clinicians to configure telehealth workflows without programming experience and integrate with electronic medical record systems. Major products and solutions include iDoc Telehealth solutions, telehealth software building blocks, VSee Clinic, VSee Messenger, VSee APIs/SDKs, Remote Patient Monitoring (RPM) tools, Telehealth Staffing, and AI-powered solutions.

VSee Health, Inc. primarily provides telehealth care solutions in the United States, but its services have been deployed in over 50 countries. The company's client base is global and includes notable organizations such as NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, GE, Magellan, and the entire nation of Qatar. The company is headquartered in Newton, Massachusetts, with a previous mention of Boca Raton, FL, and VSee Lab, Inc. being based in Sunnyvale, California.

VSee Health is recognized as a rapidly growing leader in AI-powered telehealth, redefining the digital healthcare market and trusted by over 1,000 clients. Its platform is praised for its modular, no-code/low-code approach, enabling fast customization, security, and scalability. However, some analyses from November 2025 suggest that VSee Health operates in a highly competitive telehealth platform market, focusing on small to medium-sized medical practices. Concerns were raised about a lack of significant competitive advantage or "moat," weak brand recognition outside its niche, and low switching costs for clients. The unveiling of the world's first autonomous telehealth AI robot at HIMSS 2026 likely positively impacted its reputation, showcasing innovation. The company's expansion of market presence since its Nasdaq listing in mid-2024, despite navigating short-seller activity, indicates resilience.

Key individuals listed as shareholders and directors include Milton Chen (Co-CEO and Chairman of the Board), Imoigele P. Aisiku (Co-CEO and Director), and Jerry Leonard (Chief Financial Officer and Secretary). Independent Directors include Kevin Thomas Lowdermilk, Cydonii V. Fairfax, David L. Wickersham, Colin O'Sullivan, and Scott Metzger.